Today: 1 May 2026

1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM (FLWS) Stock Jumps 30% on AI-Focused CIO Hire: Latest News, Debt Risk and 2026 Forecast

1-800-FLOWERS.COM shares jumped 32.8% to $4.94 on December 9, 2025, after naming Alexander Zelikovsky as Chief Information Officer to lead AI and digital commerce initiatives. Trading volume surged to 6.3 million shares. The stock remains down about 46% from its 52-week high, with its balance sheet and earnings still under pressure.
10 December 2025
···
Microsoft Stock (MSFT) on December 10, 2025: $23 Billion AI Bet, Analyst Targets and What It Means for Investors

Microsoft Stock (MSFT) on December 10, 2025: $23 Billion AI Bet, Analyst Targets and What It Means for Investors

Microsoft shares traded near $492 midday, valuing the company at $3.85 trillion, after announcing $23 billion in new AI infrastructure spending across India, Canada, and the U.S. The stock sits about 9% below its October record high. Wall Street targets now reach the mid-$600s, but some analysts warn current prices reflect high optimism. Microsoft reported FY 2025 revenue of $281.7 billion and net income of $101.8 billion.
10 December 2025
···
Hydro-Québec’s Power Scare, Air Transat Strike Deal and Ottawa’s Remote‑Work Pivot: What Canadians Need to Know on December 10, 2025

Hydro-Québec’s Power Scare, Air Transat Strike Deal and Ottawa’s Remote‑Work Pivot: What Canadians Need to Know on December 10, 2025

Hydro-Québec issued two internal power failure alerts on December 3 and 5 as a cold snap pushed demand near grid limits, nearly triggering rolling blackouts. The utility says the situation is under control, but critics warn of a “catastrophe.” Air Transat reached a tentative deal with pilots, ending strike threats after days of flight disruptions. Prime Minister Mark Carney signaled a stricter return-to-office plan for federal workers, raising union concerns.
10 December 2025
·
Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (XXI) Stock: NYSE Debut, Bitcoin Treasury Bet and 2026 Outlook

Twenty One Capital (NYSE: XXI) debuted on the NYSE December 9, 2025, after merging with Cantor Equity Partners. Shares fell nearly 20% on the first day, closing at $11.42 despite the company holding over 43,500 Bitcoin. Early pre-market trading on December 10 showed a slight recovery toward $12.10. Jack Mallers leads the company, with Tether, Bitfinex, and SoftBank as major backers.
10 December 2025
··
Tesla Stock (TSLA) on December 10, 2025: Price Action, China Rebound, Model Y Incentives and Wall Street Forecasts to 2030

Tesla Stock (TSLA) on December 10, 2025: Price Action, China Rebound, Model Y Incentives and Wall Street Forecasts to 2030

Tesla closed at $445.17 on Tuesday, up 1.27%, and traded in the mid-$440s pre-market Wednesday. Shares sit near the top of their 52-week range after rebounding from early 2024 lows. Q3 2025 saw record deliveries of about 497,000 vehicles and $28.1 billion in revenue, but operating margin fell to 5.8%. Trading volume remains heavy, with 60–100 million shares changing hands daily.
10 December 2025
·
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health raised its 2025–2026 profit outlook and launched an AI-driven engagement platform at its Investor Day in Hartford, sending shares up 2% to around $78 on December 10. The stock has surged nearly 80% year to date. CVS now expects at least $400 billion in 2025 revenue and adjusted EPS of $6.60–$6.70, above prior guidance. Management projects mid-teens adjusted EPS growth through 2028.
10 December 2025
··
Meta Platforms (META) Stock on December 10, 2025: AI Pivot, EU Rulings and New Price Targets

Meta Platforms (META) Stock on December 10, 2025: AI Pivot, EU Rulings and New Price Targets

Meta Platforms traded at $656–$657 per share Wednesday, down 1.5% from the previous close, with a market cap near $1.85 trillion. Shares remain below late-October highs after a sharp drop following Q3 earnings and a surge in AI spending plans. Meta is cutting Reality Labs’ budget by up to 30% and expects to spend about $72 billion on AI in 2025. The company recently invested $14 billion in Scale AI for a 49% stake.
10 December 2025
····
Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver Stock (PAAS) Hits 12‑Month High as Silver Breaks $60: What Today’s Rally Means for 2026

Pan American Silver shares hit a 12-month high of $48.78 on December 10, 2025, after jumping 11% the previous day. The surge follows silver’s move above $60 per ounce and anticipation of a Federal Reserve rate cut. Trading volume topped 17 million shares, with the company’s market cap near $20.4 billion. Strong Q3 cash flow, higher production guidance, and recent acquisitions also supported the rally.
10 December 2025
··
Broadcom (AVGO) Stock Near Record High Ahead of Q4 2025 Earnings: AI Supercycle, Analyst Upgrades and 2030 Forecasts

Broadcom (AVGO) Stock Near Record High Ahead of Q4 2025 Earnings: AI Supercycle, Analyst Upgrades and 2030 Forecasts

Broadcom shares traded at $406 on December 10, 2025, just below the 52-week high of $407.29, valuing the company at $1.92 trillion. The company reports fiscal Q4 earnings on December 11, with analysts expecting revenue near $17.5 billion and adjusted EPS of $1.88, both up sharply year over year. AI semiconductor revenue is projected at $6.2 billion, about a third of total sales.
10 December 2025
····
Nvidia (NVDA) Stock Today: Trump’s H200 Green Light, New Chip-Tracking Tech and Fresh 2026 Price Targets

Nvidia (NVDA) Stock Today: Trump’s H200 Green Light, New Chip-Tracking Tech and Fresh 2026 Price Targets

The U.S. government has approved Nvidia to resume sales of its H200 AI chips to select Chinese customers, requiring the company to share 25% of related revenue with Washington. Nvidia shares traded near $185 midday, down slightly but up nearly 40% year-to-date. The new policy does not cover Nvidia’s most advanced chips, which remain restricted. Beijing is considering its response as analysts raise 2026 forecasts.
10 December 2025
···
BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies Stock (BMNR) on December 10, 2025: Ethereum Mega‑Treasury, 50B‑Share Plan and High‑Risk 2026 Outlook

BitMine Immersion Technologies (BMNR) closed at $39.20 on December 9, 2025, up nearly 10%, with trading volume nearing $2 billion. The stock’s 52-week range spans $0.22 to $161, and its market cap fluctuates between $7–15 billion. BMNR now operates as an Ethereum-focused treasury and services platform, moving away from pure Bitcoin mining. Options activity shows heavy bullish speculation.
10 December 2025
··
Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) Stock on December 10, 2025: Violent Rally, Phase 3 FAP Progress and What 2026 Might Hold

Biodexa Pharmaceuticals (NASDAQ: BDRX) closed at $4.09 on December 9, down 53.5% from the prior session, after wild swings that saw the stock trade between $4.00 and $7.60 intraday. The company is advancing a Phase 3 trial in a rare inherited cancer syndrome and exploring new financing. Its float remains under 670,000 ADSs, fueling extreme volatility. Market cap stands near $5.5 million.
10 December 2025
··
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax shares surged as much as 20% on December 10, 2025, in Paris trading amid market rumors of a possible takeover bid by Eli Lilly. The stock hit a 52-week high near €126.60, with market value reaching about €9.7 billion. Abivax declined to comment, and no formal offer has been announced. U.S.-listed ADRs also jumped over 11% in pre-market trading.
10 December 2025
····
JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase (JPM) Stock on December 10, 2025: Expense Shock, Dividend Update and Wall Street Forecasts

JPMorgan Chase shares fell nearly 5% on December 9 after executives projected 2026 expenses of about $105 billion, well above Wall Street estimates. The bank reaffirmed its $1.50 quarterly dividend. As of late morning December 10, shares traded near $300.50, recovering from the sharpest one-day drop in eight months. Analysts remain broadly positive on the stock’s long-term outlook.
10 December 2025
··
Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont Stock Soars on Gold Rally: Latest NEM News, Analyst Forecasts and 2026 Outlook (10 December 2025)

Newmont shares rose 5.7% to $94.09 by mid-day on December 10, with trading volume near 8.7 million. The stock is up over 130% year-to-date, fueled by a surge in gold prices and company restructuring. Newmont sits just below its 52-week high of $98.58 reached in October. Analysts cite strong operational progress and increased mainstream investor interest.
10 December 2025
··
Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences shares surged over 70% in after-hours trading December 9, reaching around $10.29 after closing at $5.92, following news of a U.S. patent allowance for its EVM301 mental-health drug series. Pre-market quotes early December 10 ranged from $10.48 to $12.45 amid heavy volatility. The stock had fallen about 90% over the past year. The new patent covers both composition and method-of-use claims.
10 December 2025
Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle Stock Today: AI Bets, Debt Fears and What to Watch in Q2 FY26 Earnings

Oracle reports fiscal Q2 2026 earnings after market close, with consensus expecting revenue of $16.2 billion, up 15% year over year, and adjusted EPS of $1.64. Shares traded at $221.53 midday, up about a third in 2025. Options markets imply a 10% swing on the results. Wall Street is watching for signs that Oracle’s AI-driven cloud growth can withstand concerns over debt and customer concentration.
10 December 2025
····
Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Most Active Stocks Today: Nvidia, Tesla, PAVS, American Airlines and More Drive U.S. Market Volume on December 10, 2025

Nvidia (NVDA) led U.S. trading volume on December 10, 2025, with about 145 million shares exchanged as the stock hovered near $185. Warner Bros. Discovery (WBD) surged after a $108 billion hostile bid from Paramount Skydance. Microcaps like Paranovus (PAVS) and Senti Biosciences (SNTI) posted sharp volume spikes. Wall Street traded cautiously ahead of the Federal Reserve’s final policy decision of the year.
10 December 2025
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Dyne Therapeutics shares fell 16.9% to $18.44 after announcing a $300 million stock offering. SLM Corp dropped 15%, Kontoor Brands slid 9.5%, and Waystar Holding lost 8.4%. Major indexes were little changed as investors awaited the Federal Reserve’s interest-rate decision. The U.S. 10-year Treasury yield hovered near 4.19%.
10 December 2025
···········
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

A SPAC III Acquisition (ASPC) surged over 100% pre-market Dec. 10, trading between $25 and $31 after sharp gains in after-hours. Enveric Biosciences (ENVB) and Biodexa Pharmaceuticals (BDRX) also posted triple- and double-digit percentage gains. Major U.S. index futures were little changed ahead of the Federal Reserve’s final 2025 rate decision. Speculative micro-caps and SPACs led early trading volatility.
10 December 2025
··········
1 … 1,270 1,271 1,272 1,273 1,274 … 1,888

Stock Market Today

  • Top 3 Cryptocurrencies to Hedge Against Rising U.S. Debt and Inflation Risks
    May 1, 2026, 4:37 PM EDT. The U.S. government's interest payments have surged to $970 billion in 2025, surpassing national defense spending and raising concerns of increased money printing or "the big print." This scenario suggests rising inflation, potentially eroding the dollar's value. Fiscal experts project deficits above $2 trillion annually, limiting spending flexibility. Investors increasingly consider inflation-hedging assets. Cryptocurrencies like Bitcoin (BTC), Zcash (ZEC), and tokenized gold through Tether Gold (XAUT) offer protection. Bitcoin's capped supply combats inflation, Zcash provides privacy features, and tokenized gold represents tangible value. Allocating to these assets can help investors prepare for prolonged inflation pressures driven by U.S. fiscal dynamics.

Latest article

Oracle Stock Jumps After Pentagon AI Win, OpenAI Reassurance

Oracle Stock Jumps After Pentagon AI Win, OpenAI Reassurance

1 May 2026
Oracle shares jumped 6.4% to $171.74 after the U.S. War Department cleared the company to deploy AI on classified military networks. The move eased investor concerns over Oracle’s exposure to OpenAI and its costly AI data-center expansion. Trading volume topped 22 million shares in late New York trading.
Zoom Communications Stock Jumps as May 21 Earnings Test Puts AI Plan on Clock

Zoom Communications Stock Jumps as May 21 Earnings Test Puts AI Plan on Clock

1 May 2026
Zoom shares rose 6.6% to $103.60 Friday, trading over 4.7 million shares. The company will report first-quarter fiscal 2027 results on May 21 and hold its virtual annual meeting on June 11, where shareholders will vote on directors, auditor, and executive pay. Fourth-quarter revenue reached $1.247 billion, up 5.3% year-over-year.
GameStop’s $9 Billion Cash Pile Just Put Its Stock Back In Play

GameStop’s $9 Billion Cash Pile Just Put Its Stock Back In Play

1 May 2026
GameStop shares rose to $26.61 Friday in New York, extending gains above the 200-day moving average as investors speculated on CEO Ryan Cohen’s plans for $9 billion in cash and securities. Fiscal fourth-quarter results showed net sales down to $1.104 billion, but operating income climbed to $135.2 million. Collectibles revenue jumped 47.7% year over year, now making up 29.2% of sales.
Go toTop